Cambrex, a contract development and manufacturing organisation (CDMO), has partnered with developmental biotechnology firm Eli Lilly to offer improved access to clinical development capabilities. Working with Lilly’s early external innovation and collaboration arm, Lilly Catalyze360-ExploR&D, Cambrex will offer drug substance, product, R&D and analytical service labs to Lilly’s collaborators. Cambrex’s Longmont facility will host the primary services.

Are Facial Recognition and Passkeys the Same? Exploring Key Concepts
Explore the key differences between facial recognition and passkeys for authentication. Understand their unique concepts, security implications, and use cases in software development. The post
